本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amylyx Pharmaceuticals

33.64
+2.026.39%
成交量:192.54萬
成交額:6,382.50萬
市值:42.20億
市盈率:-23.51
高:33.96
開:31.84
低:31.57
收:31.62
52周最高:41.14
52周最低:10.83
股本:1.25億
流通股本:1.10億
量比:1.41
換手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-1.4309
每股收益(LYR):-1.5305
淨資產收益率:-74.73%
總資產收益率:-44.13%
市淨率:17.65
市盈率(LYR):-21.98

資料載入中...

2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]